NCT03393871View on ClinicalTrials.gov

Myocardial Mass Determination by FFRct and Absolute Coronary Blood Flow

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

December 1, 2018

Study Completion Date

March 1, 2019

Conditions
Fractional Flow ReserveAbsolute Flow MeasurementFFR-CTMyocardial MassCoronary Artery Disease
Interventions
DIAGNOSTIC_TEST

absolute blood flow measurement

Absolute maximum flow will be measured, using the RayFlow® multifunctional monorail infusion catheter. (This measurement takes a few minutes per artery, does not require any additional drug, but only 50-100 ml of saline per artery, and is not associated with any additional risk for the patient compared to the regular invasive procedure.

Trial Locations (1)

5623EJ

Catharina Hospital, Eindhoven

All Listed Sponsors
lead

Catharina Ziekenhuis Eindhoven

OTHER

NCT03393871 - Myocardial Mass Determination by FFRct and Absolute Coronary Blood Flow | Biotech Hunter | Biotech Hunter